Q15369 (ELOC_HUMAN) Homo sapiens (Human)
Elongin-C UniProtKBInterProSTRINGInteractive Modelling
112 aa; Sequence (Fasta) ; (Isoform 2; ) 128 identical sequences
Sequence Alignments
Experimental structures
| Description | Oligo-state | Ligands | Structure | Range |
|---|---|---|---|---|
| Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P61201; P62877; Q13098; Q13617; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | 6r7h | ||
| Assess | ||||
| Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P40337; P61201; P62877; Q13098; Q13617; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | 6r7f | ||
| Assess | ||||
| Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… |
Heteromer P40337; Q15370; Q99814; | 1×FMT; | 6i7r | |
| Assess | ||||
| von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide |
Heteromer P40337; Q15370; Q16665; | 1×GOL; | 4ajy | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol |
Heteromer P40337; Q15370; Q16665; | 1×SO4; 1×F4K; 1×GOL; | 6gmr | |
| Assess | ||||
| Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… |
Heteromer P40337; P51532; Q15370; | 1×FWZ; 1×DMS; | 6hr2 | |
| Assess | ||||
| Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… |
Heteromer P40337; Q15370; Q2KII4; Q99814; | 1×GOL; | 6i7q | |
| Assess | ||||
| Crystal structure of a B30.2/SPRY domain-containing protein GUSTAVUS in complex with Elongin B and … |
Heteromer A1Z6E0; P62869; P83940; | 2fnj | ||
| Assess | ||||
| pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… |
Heteromer P40337; Q15370; Q16665; | 6gfx | ||
| Assess | ||||
| Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex |
Heteromer P40337; Q15370; Q16665; | 1lm8 | ||
| Assess | ||||
| CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 1.9A RESOLUTION |
Heteromer O14508; Q15370; | 3×SO4; 3×NI; | 2c9w | |
| Assess | ||||
| PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL |
Heteromer P40337; Q07817; Q15370; | 1×QL8; 17×EDO; 9×GOL; 12×IOD; | 6zhc | |
| Assess | ||||
| pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate |
Heteromer P40337; Q15370; | 2×ACT; 1×F4E; | 6gmn | |
| Assess | ||||
| Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide |
Heteromer O14508; Q15370; | 1×CO; | 6i5n | |
| Assess | ||||
| pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… |
Heteromer P40337; Q15370; | 1×TG0; | 4b9k | |
| Assess | ||||
| Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… |
Heteromer P40337; Q15370; Q16665; | 1×SO4; | 1lqb | |
| Assess | ||||
| Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C |
Heteromer P40337; Q15370; Q99814; | 6bvb | ||
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… |
Heteromer P40337; Q15370; | 1×9BT; | 5nvv | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… |
Heteromer P40337; Q15370; | 1×3JU; | 4w9f | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… |
Heteromer P40337; Q15370; | 1×3JO; | 4w9k | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… |
Heteromer P40337; Q15370; | 1×9BH; | 5nw1 | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… |
Heteromer P40337; Q15370; | 1×3JF; | 4w9h | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… |
Heteromer P40337; Q15370; | 1×3JG; | 4w9c | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… |
Heteromer P40337; Q15370; | 1×3JK; | 4w9d | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… |
Heteromer P40337; Q15370; | 1×3JJ; | 4w9l | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… |
Heteromer P40337; Q15370; | 1×3JH; | 4w9j | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… |
Heteromer P40337; Q15370; | 1×4YY; | 5nvx | |
| Assess | ||||
| von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… |
Heteromer P40337; Q15370; | 1×X6C; 1×ACT; | 4bks | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… |
Heteromer P40337; Q15370; | 1×9BW; | 5nvw | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… |
Heteromer P40337; Q15370; | 1×9B8; | 5nw2 | |
| Assess | ||||
| Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; P51531; Q15370; | 1×FX8; 11×EDO; 1×FMT; | 6hay | |
| Assess | ||||
| Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… |
Heteromer O60885; P40337; Q15370; | 1×WEP; | 7khh | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… |
Heteromer P40337; Q15370; | 1×9BK; | 5nw0 | |
| Assess | ||||
| pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … |
Heteromer P40337; Q15370; | 1×EXE; | 6gfz | |
| Assess | ||||
| von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… |
Heteromer P40337; Q15370; | 1×QD0; | 4bkt | |
| Assess | ||||
| Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; P51531; Q15370; | 8×EDO; 1×FWZ; 1×EPE; | 6hax | |
| Assess | ||||
| Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC |
Heteromer P12504; Q15370; | 3dcg | ||
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… |
Heteromer P40337; Q15370; | 1×3JS; | 4w9i | |
| Assess | ||||
| pVHL:EloB:EloC in complex with VH298 |
Heteromer P40337; Q15370; | 1×6Z3; | 5lli | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… |
Heteromer P40337; Q15370; | 1×DV5; | 6fmj | |
| Assess | ||||
| pVHL:EloB:EloC complex, in complex with capped Hydroxyproline |
Heteromer P40337; Q15370; | 3×ACT; 1×V6F; | 4awj | |
| Assess | ||||
| pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… |
Heteromer P40337; Q15370; | 1×GOL; 1×ZUN; | 3zun | |
| Assess | ||||
| pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one |
Heteromer P40337; Q15370; | 1×F7B; 1×IPA; | 6gmx | |
| Assess | ||||
| CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 2.55A RESOLUTION |
Heteromer Q15370; Q8WXH5; | 1×NA; 1×EDO; 1×CL; | 2izv | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… |
Heteromer P40337; Q15370; | 1×3JT; | 4w9e | |
| Assess | ||||
| pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… |
Heteromer P40337; Q15370; | 1×TR0; | 3ztc | |
| Assess | ||||
| Crystal structure of SOCS2:Elongin C:Elongin B in complex with erythropoietin receptor peptide |
Heteromer O14508; Q15370; | 1×PEG; | 6i4x | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… |
Heteromer P40337; Q15370; | 1×3JV; | 4w9g | |
| Assess | ||||
| The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB |
Heteromer O60885; P40337; Q15370; | 1×759; | 5t35 | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… |
Heteromer P40337; Q15370; | 1×9BN; | 5nvz | |
| Assess | ||||
| THE VHL-ELONGINC-ELONGINB STRUCTURE |
Heteromer P40337; Q15370; | 1vcb | ||
| Assess | ||||
| pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … |
Heteromer P40337; Q15370; | 1×EXH; | 6gfy | |
| Assess | ||||
| pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… |
Heteromer P40337; Q15370; | 1×DV8; | 6fmk | |
| Assess | ||||
| pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… |
Heteromer P40337; Q15370; | 1×ZTD; | 3ztd | |
| Assess | ||||
| pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… |
Heteromer P40337; Q15370; | 1×DV2; | 6fmi | |
| Assess | ||||
| pVHL54-213-EloB-EloC complex_apo |
Heteromer P40337; Q15370; | 3zrf | ||
| Assess | ||||
| Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide |
Heteromer O14508; Q15370; | 1×CO; | 6i5j | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… |
Heteromer P40337; Q15370; | 1×9B5; | 5nvy | |
| Assess | ||||
| pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… |
Heteromer P40337; Q15370; | 1×L8B; | 3zrc | |
| Assess | ||||
| Structure of SOCS2:Elongin C:Elongin B from DMSO-treated crystals |
Heteromer O14508; Q15370; | 5bo4 | ||
| Assess | ||||
| Crystal structure of SIVrcm Vif-CBFbeta-ELOB-ELOC complex |
Heteromer E1ANT9; Q13951; Q15370; | 1×ZN; 1×GOL; | 6p59 | |
| Assess | ||||
| Structure of the SOCS2-Elongin BC complex bound to an N-terminal fragment of Cullin5 |
Heteromer O14508; P62869; P83940; Q93034; | 4jgh | ||
| Assess | ||||
| Crystal Structure of SOCS1 in complex with ElonginB and ElonginC |
Heteromer C0LEJ4; Q00560; Q15370; | 6c5x | ||
| Assess | ||||
| Structure of VHL-EloB-EloC-Cul2 |
Heteromer P40337; Q13617; Q15370; | 4wqo | ||
| Assess | ||||
| Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … |
Heteromer O60885; P40337; Q15370; | 1×LFE; | 6sis | |
| Assess | ||||
| Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex |
Heteromer P40337; P62877; Q13617; Q15370; | 3×ZN; | 5n4w | |
| Assess | ||||
| Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P61201; P62877; Q13098; Q13617; Q15370; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | 3×ZN; | 6r7n | |
| Assess | ||||
| SOCS box elonginBC ternary complex |
Heteromer O35718; P83940; Q15370; | 2jz3 | ||
| Assess | ||||
| Crystal Structure of Ankyrin Repeat and Socs Box-Containing Protein 9 (Asb9) in Complex with Elongi… |
Heteromer Q15370; Q96DX5; | 1×EDO; 1×PEG; 1×CL; | 3zkj | |
| Assess | ||||
| pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol |
Heteromer P40337; Q15370; | 6gmq | ||
| Assess | ||||
| pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… |
Heteromer P40337; Q15370; | 1×ACT; 1×UCK; | 4b95 | |
| Assess | ||||
| Ankyrin repeat and SOCS-box protein 9 (ASB9) in complex with ElonginB and ElonginC |
Heteromer Q15370; Q96DX5; | 1×EDO; | 3zng | |
| Assess | ||||
| Crystal structure of the Vif-CBFbeta-CUL5-ElOB-ElOC pentameric complex |
Heteromer P12504; Q13951; Q15370; Q93034; | 1×ZN; | 4n9f | |
| Assess | ||||
| Ankyrin repeat and SOCS-box protein 9 (ASB9), ElonginB (ELOB), and ElonginC (ELOC) bound to its sub… |
Heteromer P12277; Q15370; Q96DX5; | 6v9h | ||
| Assess | ||||
| HIV-1 Vif SOCS-box and Elongin BC solution structure |
Heteromer P12504; Q15370; | 2ma9 | ||
| Assess | ||||
Homology models built on isoform sequence
| Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | monomer | -1.30 | 4n9f.10.B | 100.00 | ||
| Assess | ||||||